We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$585M
AUM Growth
+$56.2M
Cap. Flow
+$17.6M
Cap. Flow %
3.01%
Top 10 Hldgs %
17.05%
Holding
830
New
329
Increased
104
Reduced
143
Closed
252

Sector Composition

Rank Sector Weight
1 Technology 17.76%
2 Consumer Discretionary 14.7%
3 Healthcare 14.64%
4 Consumer Staples 12.4%
5 Miscellaneous 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LQD icon
101
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
$1.48M 0.25%
+11,594
New +$1.48M
TMX
102
DELISTED
Terminix Global Holdings, Inc.
TMX
$1.48M 0.25%
38,273
+8,500
+29% +$361K
EFA icon
103
iShares MSCI EAFE ETF
EFA
$79.8B
$1.48M 0.25%
+21,300
New +$1.44M
JACK icon
104
Jack in the Box
JACK
$305M
$1.47M 0.25%
18,800
+5,831
+45% +$483K
SPG icon
105
Simon Property Group
SPG
$69.5B
$1.46M 0.25%
+9,800
New +$1.47M
CROX icon
106
Crocs
CROX
$5.83B
$1.46M 0.25%
34,800
-17,700
-34% -$618K
XLI icon
107
State Street Industrial Select Sector SPDR ETF
XLI
$33.2B
$1.45M 0.25%
+17,746
New +$1.42M
SHW icon
108
Sherwin-Williams
SHW
$83.8B
$1.45M 0.25%
+7,428
New +$1.42M
WMB icon
109
Williams Companies
WMB
$90.7B
$1.43M 0.24%
60,200
+36,300
+152% +$831K
QQQ icon
110
Invesco QQQ Trust
QQQ
$493B
$1.42M 0.24%
+6,700
New +$1.34M
A icon
111
Agilent Technologies
A
$44.5B
$1.42M 0.24%
+16,601
New +$1.31M
GLD icon
112
SPDR Gold Trust
GLD
$154B
$1.41M 0.24%
+9,874
New +$1.38M
WST icon
113
West Pharmaceutical
WST
$24.4B
$1.41M 0.24%
9,345
+3,500
+60% +$510K
ANSS
114
DELISTED
Ansys
ANSS
$1.4M 0.24%
+5,453
New +$1.29M
CTSH icon
115
Cognizant
CTSH
$28.7B
$1.4M 0.24%
+22,519
New +$1.39M
ZBRA icon
116
Zebra Technologies
ZBRA
$17.1B
$1.38M 0.24%
5,386
+4,314
+402% +$1.01M
KDP icon
117
Keurig Dr Pepper
KDP
$43.4B
$1.36M 0.23%
47,100
+29,900
+174% +$859K
WEN icon
118
Wendy's
WEN
$1.49B
$1.36M 0.23%
61,100
+39,900
+188% +$846K
NVRO
119
DELISTED
NEVRO CORP.
NVRO
$1.36M 0.23%
+11,541
New +$1.14M
WRB icon
120
W.R. Berkley
WRB
$25.4B
$1.35M 0.23%
44,078
+29,475
+202% +$910K
CPAY icon
121
Corpay
CPAY
$26.5B
$1.35M 0.23%
4,700
-4,900
-51% -$1.44M
LPT
122
DELISTED
Liberty Property Trust
LPT
$1.35M 0.23%
+22,500
New +$1.29M
CRM icon
123
Salesforce
CRM
$206B
$1.35M 0.23%
8,294
-25,500
-75% -$4M
EQIX icon
124
Equinix
EQIX
$106B
$1.35M 0.23%
2,310
-4,500
-66% -$2.53M
SYK icon
125
Stryker
SYK
$124B
$1.34M 0.23%
6,400
+5,200
+433% +$1.08M

Similar funds

Bayesian Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Bayesian Capital Management held 830 positions worth $585M, up 11% from $529M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Bayesian Capital Management deployed $17.6M of net new capital in Q4 2019, opening 329 new positions and adding to 104 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $11.3M trimmed.

  • Bayesian Capital Management's largest Q4 2019 buy was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
  • Bayesian Capital Management added most to Edwards Lifesciences in Q4 2019, an estimated $4.47M increase.
  • Bayesian Capital Management's biggest Q4 2019 reduction was Meta Platforms (Facebook), cutting an estimated $11.3M.
  • Bayesian Capital Management fully exited Accenture in Q4 2019, selling an estimated $12.8M.
  • Bayesian Capital Management's ten largest holdings make up 17% of its $585M portfolio in Q4 2019.
  • Bayesian Capital Management opened 329 new positions and closed 252 in Q4 2019.
  • Bayesian Capital Management's portfolio value rose 11% quarter-over-quarter to $585M.

Based on Bayesian Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.